Cointime

Integrated BioTherapeutics

company

About

AIntegrated BioTherapeutics is a focused on the discovery of novel vaccines and therapeutics for emerging infectious diseases.

  • 11 - 50

Highlights

Total Funding Amount
$6.60M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$6.60M
Industries
Biotechnology,Health Care,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2005
Number Of Employee
11 - 50
Operating Status
Active

A biotechnology company focused on the discovery of novel vaccines and therapeutics for emerging infectious diseases. It antiviral pipeline includes unique pan-filovirus antibody candidates, vaccines and a variety of other product candidates for emerging viruses.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$6.60M
Integrated BioTherapeutics has raised a total of $6.60M in funding over 2 rounds. Their latest funding was raised on Aug 2, 2017 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 2, 2017 Grant $6.60M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Integrated BioTherapeutics is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health — Grant
Cointime
เนื้อหา
บริษัท